Invention Grant
- Patent Title: Compositions and methods for treating cancer with aberrant lipogenic signaling
-
Application No.: US15434454Application Date: 2017-02-16
-
Publication No.: US09988403B2Publication Date: 2018-06-05
- Inventor: Chenguang Wang , Jie Zhou
- Applicant: Thomas Jefferson University
- Applicant Address: US PA Philadelphia
- Assignee: Thomas Jefferson University
- Current Assignee: Thomas Jefferson University
- Current Assignee Address: US PA Philadelphia
- Agency: Nixon Peabody LLP
- Agent David S. Resnick; Nicole D. Kling
- Main IPC: C07F5/04
- IPC: C07F5/04 ; A61K31/69 ; C07F7/08
Abstract:
The technology described herein relates to dimethyl boronate esters of the following formula for the treatment of cancers expressing abnormally high levels of SREBP1:
Public/Granted literature
- US20170166593A1 COMPOSITIONS AND METHODS FOR TREATING CANCER WITH ABERRANT LIPOGENIC SIGNALING Public/Granted day:2017-06-15
Information query
